| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
* Department of Biology and
Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23284;
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia; and
Laboratory of Molecular Immunoregulation, Center for Cancer Research and Basic Research Program, Science Applications International Corp.-Frederick, National Cancer Institute, MD 21702
Mouse mast cell development and survival are largely controlled by the cytokines IL-3 and stem cell factor (SCF). We have found that IL-3 stimulation of bone marrow cells induces the production of TNF via a PI3K- and MAPK kinase/ERK-dependent pathway. Specifically, Mac-1-positive cells were responsible for TNF production, which peaked on days 7–10 of culture and decreased rapidly thereafter. The importance of IL-3-induced TNF secretion was demonstrated by the failure of TNF-deficient bone marrow cells to survive for >3 wk when cultured in IL-3 and SCF, a defect that was reversed by the addition of soluble TNF. The development of human mast cells from bone marrow progenitors was similarly hampered by the addition of TNF-blocking Abs. Cell death was due to apoptosis, which occurred with changes in mitochondrial membrane potential and caspase activation. Apoptosis appeared to be due to loss of IL-3 signaling, because TNF-deficient cells were less responsive than their wild-type counterparts to IL-3-mediated survival. In vitro cultured mast cells from TNF-deficient mice also demonstrated reduced expression of the high affinity IgE receptor, which was restored to normal levels by the addition of soluble TNF. Finally, TNF-deficient mice demonstrated a 50% reduction in peritoneal mast cell numbers, indicating that TNF is an important mast cell survival factor both in vitro and in vivo.
This article has been cited by other articles:
|
|
 |
|
  K. Speiran, D. P. Bailey, J. Fernando, M. Macey, B. Barnstein, M. Kolawole, D. Curley, S. S. Watowich, P. J. Murray, C. Oskeritzian, et al. Endogenous suppression of mast cell development and survival by IL-4 and IL-10 J. Leukoc. Biol., May 1, 2009; 85(5): 826 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-i. Kashiwakura, W. Xiao, J. Kitaura, Y. Kawakami, M. Maeda-Yamamoto, J. R. Pfeiffer, B. S. Wilson, U. Blank, and T. Kawakami Pivotal Advance: IgE accelerates in vitro development of mast cells and modifies their phenotype J. Leukoc. Biol., August 1, 2008; 84(2): 357 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gounaris, S. E. Erdman, C. Restaino, M. F. Gurish, D. S. Friend, F. Gounari, D. M. Lee, G. Zhang, J. N. Glickman, K. Shin, et al. Mast cells are an essential hematopoietic component for polyp development PNAS, December 11, 2007; 104(50): 19977 - 19982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Alcaide, T. G. Jones, G. M. Lord, L. H. Glimcher, J. Hallgren, Y. Arinobu, K. Akashi, A. M. Paterson, M. A. Gurish, and F. W. Luscinskas Dendritic cell expression of the transcription factor T-bet regulates mast cell progenitor homing to mucosal tissue J. Exp. Med., February 19, 2007; 204(2): 431 - 439. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
